CHEMOMAB THERAPEUTICS LTD's ticker is CMMB and the CUSIP is 16385C104. A total of 16 filers reported holding CHEMOMAB THERAPEUTICS LTD in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $132 | -98.9% | 100 | -98.7% | 0.00% | – |
| Q1 2023 | $12,402 | -41.3% | 7,800 | +18.2% | 0.00% | – |
| Q4 2022 | $21,120 | +40.8% | 6,600 | +6.5% | 0.00% | – |
| Q3 2022 | $15,000 | -28.6% | 6,200 | +10.8% | 0.00% | – |
| Q2 2022 | $21,000 | -73.8% | 5,595 | -51.9% | 0.00% | – |
| Q4 2021 | $80,000 | +7900.0% | 11,643 | +12155.8% | 0.00% | – |
| Q3 2021 | $1,000 | -66.7% | 95 | -41.7% | 0.00% | – |
| Q2 2021 | $3,000 | -70.0% | 163 | -51.2% | 0.00% | – |
| Q1 2021 | $10,000 | – | 334 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Orbimed Advisors | 2,241,274 | $2,005,940 | 0.04% |
| Ikarian Capital, LLC | 213,392 | $190,986 | 0.02% |
| BOOTHBAY FUND MANAGEMENT, LLC | 26,529 | $23,743 | 0.00% |
| KESTRA PRIVATE WEALTH SERVICES, LLC | 31,241 | $27,961 | 0.00% |
| Qube Research & Technologies Ltd | 44 | $39 | 0.00% |
| Moser Wealth Advisors, LLC | 500 | $448 | 0.00% |
| Newbridge Financial Services Group, Inc. | 1,100 | $985 | 0.00% |
| UBS Group AG | 141 | $126 | 0.00% |
| RHUMBLINE ADVISERS | 2,843 | $2,542 | 0.00% |
| OSAIC HOLDINGS, INC. | 1,775 | $1,587 | 0.00% |